Michael Huang
Director/Board Member at Viracta Subsidiary, Inc.
Profile
Michael L.
Huang was the founder of Neurovive Pharmaceutical Asia, Inc. founded in 2014, where he held the title of Chief Executive Officer from 2014 to 2017.
Currently, he holds the position of Director at Windgap Medical, Inc. and Viracta Subsidiary, Inc. since 2021 and 2019 respectively.
He is also a Director at Regenacy Pharmaceuticals LLC, Point Robotics Medtech, Inc., Elixiron Immunotherapeutics, Inc., and Digestive Health Specialists PC.
In the past, he worked as a Director at Sunesis Pharmaceuticals, Inc., Fractyl Health, Inc., and Frequency Therapeutics, Inc. He was also an Independent Director at Viracta Therapeutics, Inc. from 2019 to 2022.
Additionally, he worked as Head-Investor Relations at TWi Pharmaceuticals, Inc. Mr. Huang completed his undergraduate studies at The University of Texas at Austin, his graduate studies at The University of Texas at Arlington, and his MBA at Jones Graduate School of Business.
Michael Huang active positions
Companies | Position | Start |
---|---|---|
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Director/Board Member | 2018-12-31 |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA. | Director/Board Member | - |
Point Robotics Medtech, Inc.
Point Robotics Medtech, Inc. Wholesale DistributorsDistribution Services Point Robotics Medtech, Inc. is a private company based in Taiwan that specializes in minimally invasive surgical technologies. In May 2020, the Taiwanese company completed its series-A fundraising from government funds, Taiwania Capital, and Translink Capital. Point Robotics Medtech will continue to focus on the development and regulatory approvals of next-generation products to maintain its leading position in the high-end surgical robotics market. Founded in 2016, the company has two major product lines\: the "Kinguide Robotic-Assisted Surgical System" and the "Kinguide Agile Hybrid Navigation System." | Director/Board Member | - |
Elixiron Immunotherapeutics, Inc.
Elixiron Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixiron Immunotherapeutics, Inc. is a privately-held biotechnology company based in Taipei, Taiwan. The Taiwanese company is focused on developing next-generation immunotherapies for unmet needs in immunological and degenerative diseases, as well as cancer. The company's drug discovery engine has allowed them to advance two clinical stage assets and several early-stage candidates. The CEO of the company is Hung-Kai Chen. | Director/Board Member | - |
Windgap Medical, Inc.
Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Windgap Medical, Inc. engages in the development of epinephrine autoinjector for the treatment of anaphylaxis. The company was founded was founded by Christopher J. Stepanian and Brent Buchine and is headquartered in Somerville, MA. | Director/Board Member | 2020-12-31 |
Digestive Health Specialists PC | Director/Board Member | - |
Former positions of Michael Huang
Companies | Position | End |
---|---|---|
VIRACTA THERAPEUTICS, INC. | Director/Board Member | 2022-08-22 |
Neurovive Pharmaceutical Asia, Inc. | Chief Executive Officer | 2016-12-31 |
TWI PHARMACEUTICALS INC | Investor Relations Contact | - |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Michael Huang
The University of Texas at Arlington | Graduate Degree |
The University of Texas at Austin | Undergraduate Degree |
Jones Graduate School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
FRACTYL HEALTH, INC. | Health Technology |
VIRACTA THERAPEUTICS, INC. | Health Technology |
Private companies | 10 |
---|---|
Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
Neurovive Pharmaceutical Asia, Inc. | |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Regenacy Pharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It develops treatments for diabetic and peripheral neuropathies. The firm provides treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors. It provides treatment for diseases such as sickle cell disease, ß-thalassemia, leukemia, and cognitive dysfunction in neurological disorders. The company was founded by Marc A. Cohen in December 2016 and is headquartered in Waltham, MA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Point Robotics Medtech, Inc.
Point Robotics Medtech, Inc. Wholesale DistributorsDistribution Services Point Robotics Medtech, Inc. is a private company based in Taiwan that specializes in minimally invasive surgical technologies. In May 2020, the Taiwanese company completed its series-A fundraising from government funds, Taiwania Capital, and Translink Capital. Point Robotics Medtech will continue to focus on the development and regulatory approvals of next-generation products to maintain its leading position in the high-end surgical robotics market. Founded in 2016, the company has two major product lines\: the "Kinguide Robotic-Assisted Surgical System" and the "Kinguide Agile Hybrid Navigation System." | Distribution Services |
TWi Pharmaceuticals, Inc.
TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Elixiron Immunotherapeutics, Inc.
Elixiron Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixiron Immunotherapeutics, Inc. is a privately-held biotechnology company based in Taipei, Taiwan. The Taiwanese company is focused on developing next-generation immunotherapies for unmet needs in immunological and degenerative diseases, as well as cancer. The company's drug discovery engine has allowed them to advance two clinical stage assets and several early-stage candidates. The CEO of the company is Hung-Kai Chen. | Health Technology |
Windgap Medical, Inc.
Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Windgap Medical, Inc. engages in the development of epinephrine autoinjector for the treatment of anaphylaxis. The company was founded was founded by Christopher J. Stepanian and Brent Buchine and is headquartered in Somerville, MA. | Health Technology |
Digestive Health Specialists PC |
- Stock Market
- Insiders
- Michael Huang